Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Bladder Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 19 articles: HTML format

Single Articles

September 2025
1. XIE J, Zhang H, Wang K, Ni J, et al
   Correction: M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.
   Oncogene. 2025 Sep 17. doi: 10.1038/s41388-025-03575.
   PubMed    
   
   
   
2. WANG Y, Jerome NA, Kelleher AJ, Henderson ML, et al
   TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.
   Oncogene. 2025 Sep 4. doi: 10.1038/s41388-025-03557.
   PubMed     Abstract available
   
   
   July 2025
3. HU H, Zhan X, Xiong Y, Yuan R, et al
   Retraction Note: Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.
   Oncogene. 2025 Jul 30. doi: 10.1038/s41388-025-03520.
   PubMed    
   
   
   
4. LUO Y, Zeng Y, Liu Y, Liu S, et al
   ACSL5 regulated acetyl-CoA to promote bladder cancer cellular senescence via 53BP1 acetylation.
   Oncogene. 2025 Jul 1. doi: 10.1038/s41388-025-03474.
   PubMed     Abstract available
   
   
   June 2025
5. ZHANG B, Dong G, Guo X, Li H, et al
   SFXN1 promotes bladder cancer metastasis by restraining PINK1-dependent mitophagy.
   Oncogene. 2025 Jun 4. doi: 10.1038/s41388-025-03460.
   PubMed     Abstract available
   
   
   May 2025
6. WEI X, Wang B, Yang Y, Fang Z, et al
   Crosstalk between SUMOylation and ubiquitination controls the stability of transcription factor zinc finger protein 24: a novel antitumor mechanism in bladder cancer.
   Oncogene. 2025 May 28. doi: 10.1038/s41388-025-03450.
   PubMed     Abstract available
   
   
   
7. HAMADA A, Kita Y, Sakatani T, Nakamura K, et al
   PTEN loss drives p53 LOH and immune evasion in a novel urothelial organoid model harboring p53 missense mutations.
   Oncogene. 2025;44:1336-1349.
   PubMed     Abstract available
   
   
   April 2025
8. HU H, Zhan X, Xiong Y, Yuan R, et al
   Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.
   Oncogene. 2025 Apr 19. doi: 10.1038/s41388-025-03410.
   PubMed     Abstract available
   
   
   
9. WU CH, Yuen KL, Molony RD, Silvers CR, et al
   Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder.
   Oncogene. 2025 Apr 11. doi: 10.1038/s41388-025-03380.
   PubMed     Abstract available
   
   
   August 2024
10. DU K, Luo Y, Zhang L, Zeng Y, et al
    m(6)A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis.
    Oncogene. 2024 Aug 28. doi: 10.1038/s41388-024-03139.
    PubMed     Abstract available
    
    
    
11. WANG X, Guo T, Niu L, Zheng B, et al
    Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis.
    Oncogene. 2024 Aug 18. doi: 10.1038/s41388-024-03136.
    PubMed     Abstract available
    
    
    January 2024
12. CAI H, Ke ZB, Chen JY, Li XD, et al
    Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1.
    Oncogene. 2024 Jan 13. doi: 10.1038/s41388-023-02936.
    PubMed     Abstract available
    
    
    
13. ZHOU F, Deng Z, Shen D, Lu M, et al
    DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11.
    Oncogene. 2024 Jan 5. doi: 10.1038/s41388-023-02932.
    PubMed     Abstract available
    
    
    December 2023
14. YU J, Li M, Ju L, Zhou F, et al
    TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC.
    Oncogene. 2023 Dec 20. doi: 10.1038/s41388-023-02922.
    PubMed     Abstract available
    
    
    November 2023
15. RAMAL M, Corral S, Kalisz M, Lapi E, et al
    The urothelial gene regulatory network: understanding biology to improve bladder cancer management.
    Oncogene. 2023 Nov 23. doi: 10.1038/s41388-023-02876.
    PubMed     Abstract available
    
    
    August 2023
16. XIE J, Zhang H, Wang K, Ni J, et al
    M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription.
    Oncogene. 2023 Aug 23. doi: 10.1038/s41388-023-02814.
    PubMed     Abstract available
    
    
    May 2023
17. JIA Y, Ding X, Zhou L, Zhang L, et al
    Retraction Note: Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.
    Oncogene. 2023 May 30. doi: 10.1038/s41388-023-02726.
    PubMed    
    
    
    March 2023
18. NEYRET-KAHN H, Fontugne J, Meng XY, Groeneveld CS, et al
    Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks.
    Oncogene. 2023 Mar 22. doi: 10.1038/s41388-023-02662.
    PubMed     Abstract available
    
    
    
19. SUN J, Zhang H, Wei W, Xiao X, et al
    Regulation of CD8(+) T cells infiltration and immunotherapy by circMGA/HNRNPL complex in bladder cancer.
    Oncogene. 2023 Mar 3. doi: 10.1038/s41388-023-02637.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.